|
Contact
information:
Telephone: (514) 934-1934, ext.
43810
e-mail address:
brian.ward@mcgill.ca
website:
http://www.mcgill.ca/hostres/investigators/ward/
http://www.mcgill.ca/microimm/department/associate_adjunct_prof/ward/
Projects for Thesis
Supervision:
1. Retinoid-virus interactions.
2. Respiratory virus vaccine
development (nasal, adjuvants, cutaneous, plant-based antigens, VLPs).
3. Biomarkers for infectious
diseases.
Recent
Publications:
Trottier C, Chabot S, Mann C,
Miller W, Ward BJ.
Retinoic acid inhibits measles virus replication in bystander cells
through type-I interferon signaling pathways. FASEB J 2009 (in press).
Berrizbeitia M, Ndao M, Bubi J, Gottscjalk M,
Ache A, Perdomo D, Medina R, Spencer L,
Ward BJ.
85-kDa protein of Trypanosoma cruzi purified by affinity
chromatography used in the multiple antigen binding assay (MABA) for the
diagnosis of Chagas disease in a Venezuelan rural community. Am J Trop
Med & Hygiene 2009 (in press).
Cyr SL, Angers I, Stoica-Popescu I, Lussier M,
Qureshi S, Burt D, Ward BJ.
Intranasal, protollin-based RSV vaccination in mice: TLR4/MyD88
signaling is required both for protection and the control of pulmonary
granulocyte recruitment following challenge. Vaccine 2009; 27: 421-30.
|
